When type II pneumonocytes from adult rats were maintained in a medium that lacked choline, the incorporation of ['4C]glycerol into phosphatidylcholine was not greatly diminished during the period that the cells displayed characteristics of type II pneumonocytes. Cells that were maintained in choline-free medium that contained choline oxidase and catalase, however, became depleted of choline and subsequent synthesis of phosphatidylcholine by these cells was responsive to choline in the extracellular medium. Incorporation of ['4C]glycerol into phosphatidylcholine by cholinedepleted cells was stimulated maximally (approx. 6-fold) by extracellular choline at a concentration (0.05mM) that also supported the greatest incorporation into phosphatidylglycerol. The 
The most abundant glycerophospholipids of the surfactant that is produced by type II pneumonocytes of mature lungs are phosphatidylcholine and phosphatidylglycerol (Body, 1971; Pfleger & Thomas, 1971) . The surfactant produced by immature lungs, however, contains phosphatidylinositol in place of phosphatidylglycerol (Hallman & Gluck, 1975; Hallman et al., 1977) . Foetal lung *Present address: Clinica Ostetrica e Ginecologica R, Policlinico Monteluce, 06100 Perugia, Italy. maturation in several species is accompanied by a developmental decline in the amount of phosphatidylinositol in lung surfactant that is concomitant with an increase in the phosphatidylglycerol content of surfactant (Hallman & Gluck, 1980) . There is indirect evidence that phosphatidylglycerol may be essential for proper surfactant function (Hallman et al., 1976) but the role of phosphatidylglycerol in surfactant remains unknown (Beppu et al., 1983) . The mechanisms that operate within the type II pneumonocyte to regulate the Vol. 224 biosynthesis of phosphatidylglycerol and phosphatidylinositol from their common precursor, CDP-diacylglycerol, are not well understood. There is evidence, however, that CDPdiacylglycerol: inositol 3-phosphatidyltransferase (EC 2.7.8.11, the enzyme that catalyses the final reaction in phosphatidylinositol biosynthesis) is involved in the regulation of phosphatidylglycerol biosynthesis (Bleasdale et al., 1979; Quirk et al., 1980; Bleasdale & Johnston, 1982a) . First, activity of this enzyme in type II pneumonocytes is sensitive to developmental changes in the availability of myo-inositol; when the concentration of myo-inositol in foetal serum decreases in late gestation, CDP-diacylglycerol: inositol 3-phosphatidyltransferase activity decreases and more CDP-diacylglycerol is available for phosphatidylglycerol biosynthesis (Bleasdale et al., 1982) . Second, CDP-diacylglycerol inositol 3-phosphatidyltransferase catalyses a reversible reaction and the reverse reaction is promoted by CMP (Bleasdale et al., 1979) . Intracellular amounts of CMP in foetal lung tissue increase in late gestation as a result of enhanced phosphatidylcholine synthesis for surfactant (Quirk et al., 1980) . Consequently, the net biosynthesis ofphosphatidylinositol decreases and more CDP-diacylglycerol is available for phosphatidylglycerol biosynthesis. The objective of this investigation was to alter the rate of phosphatidylcholine biosynthesis by type II pneumonocytes and to examine the effect on the rate of biosynthesis of phosphatidylglycerol. Since the rate of phosphatidylcholine synthesis by type II pneumonocytes in vitro can be increased relatively little by hormones (G. C. Di Renzo & J. E. Bleasdale, unpublished work; Post et al., 1980) (with or without choline) was prepared by using chemicals obtained from Sigma Chemical Co. The sources of all other materials have been described previously (Bleasdale et al., 1982 (Bleasdale et al., , 1983 . Type II pneumonocytes were isolated by a modification of the method of Mason et al. (1977a,b) as described elsewhere (Bleasdale et al. 1982 ).
Choline-depletion and incubation of cells Isolated cells were washed once by suspending in Dulbecco's modified Eagle's medium that contained antibiotics and an antimycotic (Bleasdale et al., 1982 ) (referred to subsequently as medium) followed by centrifugation at 250g for 6min. The washed cell pellet was resuspended in medium. Cells (approx. 2x 106 in 1 ml of medium) were incubated in glass screw-cap culture tubes (150 mm x 20 mm) in an incubator at 37°C.
[14C]Glycerol (0.07mM, approx. 30Ci/mol) was added to the cell suspension and incubation was continued for 12h unless stated otherwise. For most experiments, however, incubation of the cells with [14C]glycerol was preceded by treatment of the cells with choline oxidase and catalase as follows. The washed cell pellet (consisting of approx. 5 x 10 cells) was resuspended in 10ml of choline-free medium that contained choline oxidase (1.3mg of protein) and catalase (0.08mg of protein) and the mixture was incubated at 37°C for 3 h. The cells were then collected by centrifugation (250g for 6min) and washed twice in choline-free medium before being resuspended in medium that contained [14C]glycerol (0.07mM, approx. 3OCi/ mol) and choline at various concentrations. Cells were then incubated as described above. After incubation, 4.5ml of chloroform/methanol (1:2, v/v) and 0.1 ml of HCI (6M) were added to each tube and lipids were extracted (Bleasdale et al., 1979) . Glycerophospholipids in the total lipid extract were separated by using the two-dimensional t.l.c. system of Yavin & Zutra (1977) (Bleasdale et al., 1983) .
Analysis of cytidine nucleotides
In some experiments, cells were incubated in the presence of [3H] cytidine (60 Mm, 135 Ci/mol). After incubation, the cells were washed and radiolabelled cytidine nucleotides were extracted with 3% (v/v) HC104 (Quirk et al., 1980) (Khym, 1975) and then subjected to t.l.c. on 20cm x 20cm plates of poly(ethyleneimine)-cellulose (pre-washed with water) which were developed sequentially in one dimension using 0.1M-LiCl (for the first 10cm of migration) and 1.4M-LiCl (for the remaining 8 cm of migration). Cytidine nucleotides on chromatograms were located under u.v. light and areas corresponding to cytidine, CMP, CDP, CTP and CDP-choline were scraped into scintillation vials. Scintillation fluid (lOml) and 0.85ml of 3.5M-HCI were added to each vial and radioactivity was assayed (Bleasdale et al., 1979) . When intracellular CMP was quantified, nucleotides were extracted from cells with 3% (v/v) HC104 and the acid extracts were neutralized (as described above but omitting carrier nucleotides). CMP was separated and quantified using h.p.l.c. on a Whatman Partisil 10 SAX column (lO gm particle size, 25cm x 0.46 cm) as described by Hartwick & Brown (1975) . Data were corrected for the recovery of each nucleotide as described (Quirk et al., 1980) .
Analysis of choline and its derivatives
For the measurement of incorporation of 3H into intracellular choline, phosphocholine, CDP-choline and betaine, cells that had been incubated in medium which contained [3H]choline (at various concentrations) were collected by centrifugation (250g for 6min) and washed once with medium. Each cell pellet was resuspended in 1.Oml of methanol/water (5:4, v/v) and cells were disrupted with ultrasound for 30s (Bransonic 220 bath sonicator) (Post et al., 1982) . Choline (0.4mg), phosphocholine (1 mg) and CDP-choline (2mg)
were added to each sample together with chloroform (1.5ml), methanol (0.95ml) and water (0.75 ml). After mixing well, samples were centrifuged (SOOg for 10min) to separate phases. Each upper phase was removed and evaporated under N2. Each resulting residue was redissolved in water (0.1 ml) and an aliquot (0.04 ml) was subjected to t.l.c. for the separation of choline and its derivatives . Areas of each chromatogram were scraped into scintillation vials and radioactivity was assayed (Bleasdale et al., 1979) . Identification of choline and its derivatives in cell extracts was confirmed by co-migration with authentic standards in a second chromatographic system. Forthis purpose ascending paper chromatography on Whatman no. 1 paper developed in butan-l-ol/water/1 M-aceticacid/ethanol(3:3:1:2, by vol.) was performed (Haubrich et al., 1974) .
When intracellular amounts of choline were measured, cells were disrupted by ultrasound (as described above) and then immersed in a boilingwater bath for 10min. The disrupted cells were centrifuged at lOOOOg for 5 min and aliquots of the supernatant fluids were taken for the assay of choline as described by Muneshige et al. (1983) , except that phenol was replaced by 2-hydroxy-3,5-dichlorobenzenesulphonate (1.9mM) (McGowan et al., 1983) and the concentration of 4-aminoantipyrine that was employed was 0.8 mM.
Assay of CTP:phosphocholine cytidylyltransferase activity CTP: phosphocholine cytidylyltransferase (EC 2.7.7.15) activity was assayed employing a modification of the method described by Pelech et al. (1981) . Cells were resuspended in Tris/succinate solution (30mM, pH 6.5) that contained NaF (10mM) and EDTA (1 mM) and were disrupted using ultrasound (as described above) followed by homogenization in a glass/glass hand-held homogenizer (12 strokes). Saline solution was added to each cell homogenate until the final concentration of NaCl was 154mM. The assay mixture consisted of Tris/succinate buffer (30mM, pH6.5), magnesium acetate (10mM), CTP (5mM), [I4C]phosphocholine (1 mM, 2.5 Ci/mol) and cell homogenate (approx. 60jug of protein) in a total volume of 0.1 ml. Incubations were continued for 20 min at 37°C, and then were terminated by immersion in boiling water for 2min. Heat-denatured proteins were removed by centrifugation (2000g for 1Omin) and [14C]phosphocholine and [14C]CDP-choline in an aliquot (0.04ml) of the supernatant fluid were separated by t.l.c. after adding 0.01 ml of CDP-choline (100mg/ml) as carrier. ['4C]CDP-choline was quantified by liquidscintillation spectrometry using a scintillation fluid that contained Triton X-100 (Bleasdale et al., 1979) . The rate of CTP: phosphocholine cytidylyltransferase activity was proportional to the amount of protein employed (up to lOO,ug) and for a given amount of protein was constant for 20min.
Statistical significance between mean values was assessed by Student's t-test (Zar, 1974) . Differences were considered significant at P <0.05. Other methods that were employed have been described previously (Bleasdale et al., 1982) .
Results
In a previous investigation, we measured the rate of incorporation of [14C]glycerol into phosphatidylcholine by type II pneumonocytes that were maintained in medium that contained choline (Bleasdale et al., 1983) . In the present investigation it was observed that the rate of incorporation of
[I4C]glycerol into phosphatidylcholine by untreated type II pneumonocytes was not greatly affected by withdrawal of choline from the medium (Fig. 1) only 29-50% during the period 14-24 h after choline withdrawal. After longer periods of incubation, incorporation of ['4C]glycerol into phosphatidylcholine declined markedly when cells were in either normal or choline-free medium (Fig. 1) . Type II pneumonocytes in choline-free medium apparently contained sufficient choline to support normal biosynthesis of phosphatidylcholine in the short-term. For these reasons, we evaluated procedures for increasing the effect of choline on the incorporation of ['4C]glycerol into phosphatidylcholine after relatively short periods of incubation. It was found that type II pneumonocytes could be depleted of choline by treating the cells with choline-free medium that contained choline oxidase and catalase. The bacterial choline oxidase that was employed catalyses the two-step conversion of choline to betaine (Ikuta et al., 1977) .
Catalase was included to protect the cells from H202 which is a co-product of the reactions catalysed by choline oxidase. When the amount of intracellular choline was quantified, it was found that exposure of cells to choline-free medium that contained choline oxidase resulted in a significant decrease in intracellular choline from 250+75 to 84 + 20pmol/106 cells (mean + S.D., seven experiments). Assay sensitivity and the limited availability of cells precluded direct measurement of intracellular CDP-choline. Therefore, to investigate the effect ofthe choline-depletion procedure on intracellular choline derivatives, type II pneumonocytes were incubated for either 3 h or 12 h in medium that contained [3H]choline (0.03 mM) and then were transferred to fresh medium that contained either non-radiolabelled choline (0.03 mM) or choline oxidase plus catalase. After 3 h in fresh medium, cells were separated from medium, washed twice and the amounts of 3H in intracellular choline, phosphocholine, CDP-choline and phosphatidylcholine and in extracellular choline, betaine and phosphatidylcholine were quantified (Table 1) . In preliminary experiments (results not shown), it was found that exposure to [3H]choline for more than 5 h was required before intracellular water-soluble choline derivatives reached isotopic equilibrium. As summarized in Table 1 , however, the effect of the choline-depletion procedure on the distribution of 3H among intracellular choline derivatives was qualitatively similar in cells that were exposed previously for either 3h or 12h to [3H]choline. The choline-depletion procedure did not affect the total recovery of intracellular and extracellular 3H, or the amount of 3H in intracellular CDP-choline and phosphatidylcholine. Recovery of 3H in intracellular choline and phosphocholine was diminished by the choline-depletion procedure. Some of the 3H [14C]glycerol, the incorporation of 14C into phosphatidylcholine was increased approx. 6-fold when the concentration of choline in the medium was increased (Fig. 2) . The incorporation of [14C]glycerol into phosphatidylglycerol also was greatest at the concentration of choline (0.05mM) that supported the greatest incorporation into phosphatidylcholine. The incorporation of 14C into phosphatidylinositol was unaffected and the incorporation of 14C into phosphatidylethanolamine decreased only 27% as the concentration of choline in the medium was increased (Fig. 3) . With increasing concentration of extracellular choline, the incorporation of [14C]glycerol into triacylglycerol decreased, that into diacylglycerol increased (Fig. 3) (Fig.  4) . At higher concentrations of extracellular [3H]choline, however, [3H]phosphocholine was by far the most highly radiolabelled choline derivative (Fig. 5) . These data are consistent with previous reports that in many tissues the formation of CDPcholine (catalysed by CTP :phosphocholine cytidylyltransferase) is a rate-limiting reaction in the incorporation of choline into phosphatidylcholine (see Vance & Choy, 1979 , for a review). For this reason, the possibility that the specific activity of CTP: phosphocholine cytidylyltransferase may respond to changes in the extracellular concentration of choline was also examined. Type II pneumonocytes were depleted of choline for 3 h and then transferred to medium that either lacked or contained choline (0.05mM) and were incubated for 12 h. Type II pneumonocytes were then harvested by centrifugation (250g for 10min), washed once, and then disrupted as described in the Materials and methods section. CTP:phosphocholine cytidylyltransferase activi- ties in the cell homogenates were measured. Specific activity of CTP: phosphocholine cytidylyltransferase in homogenates of type II pneumonocytes that were maintained for 12 h in choline-free medium (1.31 + 0.20 nmol -minm-* mg of protein-') was significantly greater than that of homogenates of cells exposed to choline (0.05 mM) (0.40+0.15 nmol-minrI-mg of protein-') (mean + S.D., five experiments). The lower measured activity of CTP: phosphocholine cytidylyltransferase in cells exposed to choline was not due to an increased amount of phosphocholine in such cells leading to a decrease in the specific radioactivity of the [3H]phosphocholine that was employed as substrate in the enzyme assay. In a typical experiment, the activities of CTP: phosphocholine cytidylyltransferase in homogenates of normal cells, of choline-depleted cells and of a mixture of equal amounts (mg of protein) of each homogenate were 0.43, 1.25 and 0.86 nmol . minm-' mg of protein-' respectively.
We have previously presented evidence that CMP may be involved in the integration of the biosynthesis of phosphatidylglycerol with that of phosphatidylcholine (Bleasdale & Johnston, 1982a,b; Quirk et al., 1980 (Mason & Dobbs, 1980; Bleasdale et al., 1983) . Batenburg et al. (1982) Weinhold et al., 1981) . Choline-depletion of type II pneumonocytes resulted in an activation of CTP: phosphocholine cytidylyltransferase. Characteristics of this activation are described elsewhere (Anceschi & Bleasdale, 1984) . The mechanism of activation of CTP :phosphocholine cytidylyltransferase is currently under investigation; however, mechanisms by which the activity of this enzyme may be controlled in other tissues have been described (e.g., Feldman et al., 1978; Pelech et al., 1983; Sleight & Kent, 1983) . It should be noted that the increase in CTP: phosphocholine cytidylyltransferase activity that was observed in cholinedepleted type II pneumonocytes was rapid and so is likely to be unrelated to the slow decrease in activity of this enzyme that was observed in the livers of rats that were fed a choline-deficient diet for more than 48h (Schneider & Vance, 1978) . In type II pneumonocytes, the stimulation of phosphatidylcholine synthesis by choline was associated with an apparent diversion of some diacylglycerol away from triacylglycerol synthesis while phosphatidylethanolamine synthesis was largely spared. Furthermore, stimulation of phosphatidylcholine synthesis was accompanied by increased total utilization of CDP-diacylglycerol and a redirection of CDP-diacylglycerol in favour of phosphatidylglycerol synthesis. The extracellular concentration of choline that supported the greatest incorporation of [14C]glycerol into phosphatidylcholine by choline-depleted type II pneumonocytes was that which also supported greatest incorporation of ['4C]glycerol into phosphatidylglycerol and resulted in the greatest recovery of [3H]cytidine in CMP. The increased recovery of [3H]CMP was found to reflect an increase in the intracellular concentration of CMP and this is consistent with our proposition that CMP is involved in the integration of the biosynthesis of phosphatidylcholine and that of phosphatidylglycerol (Bleasdale & Johnston, 1982b) . In this integration, it was envisioned that the reversible reaction that is catalysed by CDPdiacylglycerol: inositol 3-phosphatidyltransferase is near equilibrium in vivo and is responsive to changes in the intracellular concentrations of CMP and myo-inositol. CMP is a product of the reaction catalysed by cholinephosphotransferase and the intracellular concentrations of CMP increase at a time in foetal lung development when the biosynthesis of phosphatidylcholine for surfactant is stimulated (Quirk et al., 1980) . By promoting the reverse reaction catalysed by CDP-diacylglycerol:inositol 3-phosphatidyltransferase, CMP inhibits the biosynthesis of phosphatidylinositol (relative to that of phosphatidylglycerol) and increases the availability of CDP-diacylglycerol (synthesized from phosphatidic acid) for the biosynthesis of phosphatidylglycerol. Similarly, a decline in the availability of myo-inositol for the foetal lungs that occurs in late gestation (Bleasdale et al., 1982) results in an increase in the synthesis of phosphatidylglycerol at the expense of phosphatidylinositol biosynthesis (Hallman & Gluck, 1980; Bleasdale et al., 1983) . Thus the developmental decline in myo-inositol availability complements the developmental increase in the intracellular concentration of CMP and both promote phosphatidylglycerol biosynthesis by type II pneumonocytes [and do not act antagonistically as proposed by Batenburg et al. (1982) ].
The results of this investigation are indicative that the choline-depleted type II pneumonocyte may be a suitable experimental model for examining the regulation of CTP: phosphocholine cytidylyltransferase activity and for investigating the integration between the biosynthesis of phosphatidylcholine and that of phosphatidylglycerol.
